ANGELA WILLETT: Open Payments
NPI 1558348573 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,204 in 163 payments from 17 companies in 2025. Trend: 2023 $1,054 · 2024 $2,515 · 2025 $3,204
Food & beverage: $3,204
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $666 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $519 |
| Phathom Pharmaceuticals, Inc. | 33 | $463 |
| ABBVIE INC. | 24 | $371 |
| Madrigal Pharmaceuticals | 12 | $282 |
| QOL Medical, LLC | 9 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $192 |
| Ardelyx, Inc. | 6 | $163 |
| Lilly USA, LLC | 6 | $116 |
| PFIZER INC. | 4 | $67 |
Products named: TREMFYA, VOQUEZNA, ENTYVIO, REZDIFFRA, Sucraid, XIFAXAN, IBSRELA, SKYRIZI.
Industry payments across KY — which companies pay providers there.
